Cargando…

Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii

[Image: see text] β-Lactam resistance in Acinetobacter baumannii presents one of the greatest challenges to contemporary antimicrobial chemotherapy. Much of this resistance to cephalosporins derives from the expression of the class C β-lactamase enzymes, known as Acinetobacter-derived cephalosporina...

Descripción completa

Detalles Bibliográficos
Autores principales: Powers, Rachel A., Swanson, Hollister C., Taracila, Magdalena A., Florek, Nicholas W., Romagnoli, Chiara, Caselli, Emilia, Prati, Fabio, Bonomo, Robert A., Wallar, Bradley J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2014
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263437/
https://www.ncbi.nlm.nih.gov/pubmed/25380506
http://dx.doi.org/10.1021/bi500887n
_version_ 1782348569549733888
author Powers, Rachel A.
Swanson, Hollister C.
Taracila, Magdalena A.
Florek, Nicholas W.
Romagnoli, Chiara
Caselli, Emilia
Prati, Fabio
Bonomo, Robert A.
Wallar, Bradley J.
author_facet Powers, Rachel A.
Swanson, Hollister C.
Taracila, Magdalena A.
Florek, Nicholas W.
Romagnoli, Chiara
Caselli, Emilia
Prati, Fabio
Bonomo, Robert A.
Wallar, Bradley J.
author_sort Powers, Rachel A.
collection PubMed
description [Image: see text] β-Lactam resistance in Acinetobacter baumannii presents one of the greatest challenges to contemporary antimicrobial chemotherapy. Much of this resistance to cephalosporins derives from the expression of the class C β-lactamase enzymes, known as Acinetobacter-derived cephalosporinases (ADCs). Currently, β-lactamase inhibitors are structurally similar to β-lactam substrates and are not effective inactivators of this class C cephalosporinase. Herein, two boronic acid transition state inhibitors (BATSIs S02030 and SM23) that are chemically distinct from β-lactams were designed and tested for inhibition of ADC enzymes. BATSIs SM23 and S02030 bind with high affinity to ADC-7, a chromosomal cephalosporinase from Acinetobacter baumannii (K(i) = 21.1 ± 1.9 nM and 44.5 ± 2.2 nM, respectively). The X-ray crystal structures of ADC-7 were determined in both the apo form (1.73 Å resolution) and in complex with S02030 (2.0 Å resolution). In the complex, S02030 makes several canonical interactions: the O1 oxygen of S02030 is bound in the oxyanion hole, and the R1 amide group makes key interactions with conserved residues Asn152 and Gln120. In addition, the carboxylate group of the inhibitor is meant to mimic the C(3)/C(4) carboxylate found in β-lactams. The C(3)/C(4) carboxylate recognition site in class C enzymes is comprised of Asn346 and Arg349 (AmpC numbering), and these residues are conserved in ADC-7. Interestingly, in the ADC-7/S02030 complex, the inhibitor carboxylate group is observed to interact with Arg340, a residue that distinguishes ADC-7 from the related class C enzyme AmpC. A thermodynamic analysis suggests that ΔH driven compounds may be optimized to generate new lead agents. The ADC-7/BATSI complex provides insight into recognition of non-β-lactam inhibitors by ADC enzymes and offers a starting point for the structure-based optimization of this class of novel β-lactamase inhibitors against a key resistance target.
format Online
Article
Text
id pubmed-4263437
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-42634372015-11-07 Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii Powers, Rachel A. Swanson, Hollister C. Taracila, Magdalena A. Florek, Nicholas W. Romagnoli, Chiara Caselli, Emilia Prati, Fabio Bonomo, Robert A. Wallar, Bradley J. Biochemistry [Image: see text] β-Lactam resistance in Acinetobacter baumannii presents one of the greatest challenges to contemporary antimicrobial chemotherapy. Much of this resistance to cephalosporins derives from the expression of the class C β-lactamase enzymes, known as Acinetobacter-derived cephalosporinases (ADCs). Currently, β-lactamase inhibitors are structurally similar to β-lactam substrates and are not effective inactivators of this class C cephalosporinase. Herein, two boronic acid transition state inhibitors (BATSIs S02030 and SM23) that are chemically distinct from β-lactams were designed and tested for inhibition of ADC enzymes. BATSIs SM23 and S02030 bind with high affinity to ADC-7, a chromosomal cephalosporinase from Acinetobacter baumannii (K(i) = 21.1 ± 1.9 nM and 44.5 ± 2.2 nM, respectively). The X-ray crystal structures of ADC-7 were determined in both the apo form (1.73 Å resolution) and in complex with S02030 (2.0 Å resolution). In the complex, S02030 makes several canonical interactions: the O1 oxygen of S02030 is bound in the oxyanion hole, and the R1 amide group makes key interactions with conserved residues Asn152 and Gln120. In addition, the carboxylate group of the inhibitor is meant to mimic the C(3)/C(4) carboxylate found in β-lactams. The C(3)/C(4) carboxylate recognition site in class C enzymes is comprised of Asn346 and Arg349 (AmpC numbering), and these residues are conserved in ADC-7. Interestingly, in the ADC-7/S02030 complex, the inhibitor carboxylate group is observed to interact with Arg340, a residue that distinguishes ADC-7 from the related class C enzyme AmpC. A thermodynamic analysis suggests that ΔH driven compounds may be optimized to generate new lead agents. The ADC-7/BATSI complex provides insight into recognition of non-β-lactam inhibitors by ADC enzymes and offers a starting point for the structure-based optimization of this class of novel β-lactamase inhibitors against a key resistance target. American Chemical Society 2014-11-07 2014-12-09 /pmc/articles/PMC4263437/ /pubmed/25380506 http://dx.doi.org/10.1021/bi500887n Text en Copyright © 2014 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Powers, Rachel A.
Swanson, Hollister C.
Taracila, Magdalena A.
Florek, Nicholas W.
Romagnoli, Chiara
Caselli, Emilia
Prati, Fabio
Bonomo, Robert A.
Wallar, Bradley J.
Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
title Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
title_full Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
title_fullStr Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
title_full_unstemmed Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
title_short Biochemical and Structural Analysis of Inhibitors Targeting the ADC-7 Cephalosporinase of Acinetobacter baumannii
title_sort biochemical and structural analysis of inhibitors targeting the adc-7 cephalosporinase of acinetobacter baumannii
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4263437/
https://www.ncbi.nlm.nih.gov/pubmed/25380506
http://dx.doi.org/10.1021/bi500887n
work_keys_str_mv AT powersrachela biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii
AT swansonhollisterc biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii
AT taracilamagdalenaa biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii
AT floreknicholasw biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii
AT romagnolichiara biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii
AT caselliemilia biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii
AT pratifabio biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii
AT bonomoroberta biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii
AT wallarbradleyj biochemicalandstructuralanalysisofinhibitorstargetingtheadc7cephalosporinaseofacinetobacterbaumannii